Uncovering possible silent acquired long QT syndrome using exercise stress testing in long‐term pediatric acute lymphoblastic leukemia survivors

Audrey Harvey,Maxime Caru,Cecilia Gonzalez Corcia,Émilie Bertrand,Vincent Gagné,Smita Dandekar,Maja Krajinovic,Hugo Gravel,Caroline Laverdière,Marie‐Josée Raboisson,Gregor Andelfinger,Vincent Jacquemet,Daniel Sinnett,Daniel Curnier

DOI: https://doi.org/10.1002/ijc.35168

2024-09-09

International Journal of Cancer

Abstract:What's new? Acquired long QT syndrome is a common anthracycline‐induced cardiotoxic effect that puts cancer survivors at high risk of sudden cardiac death. This cross‐sectional study with exploratory analysis evaluated possible silent acquired long QT syndrome in 250 long‐term childhood acute lymphoblastic leukemia survivors using exercise stress testing. Seventy‐per‐cent of the survivors with abnormal QT presented no QT interval anomalies at rest but developed various anomalies during exercise. The embedding of standardized exercise testing within regular patient follow‐up is necessary for appropriate cardiac prevention and surveillance in the ever‐increasing number of cancer survivors. An example of chemotherapy‐induced cardiotoxicity in cancer survivors is acquired long QT syndrome (aLQTS), which may cause serious yet preventable life‐threatening consequences. Our objective was to identify and characterize childhood acute lymphoblastic leukemia (ALL) survivors with possible aLQTS using maximal exercise testing. In this cross‐sectional study with exploratory analysis, a total of 250 childhood ALL survivors were evaluated for abnormal QT interval prolongation using the McMaster cycle exercise test. A total of 198 survivors (102 males; 96 females), having reached their V̇O2 peak (mean 32.1 ± 8.4 mL/kg/min; range 15.5–57.8 mL/kg/min), were included in our analyses. Two survivors were excluded for possible congenital LQTS. QT intervals were corrected for heart rate using the Bazett, Fridericia, and Rautaharju formulas at rest (supine, sitting, and standing positions), at the end of each stage of the CPET, and at 1, 3, and 5 minutes into the recovery period. The corrected QT (QTc) of borderline (n = 37) and long QT survivors (n = 20) was significantly longer than normal survivors (n = 141) at rest, exercise, and recovery. Out of 57 survivors presenting an abnormal QTc prolongation, 40 survivors (70%) showed no QT interval anomalies at rest but developed various anomalies during exercise. No significant differences were found between the groups for any of the measured clinical characteristics or cardiac parameters. The standardization of exercise testing in the regular follow‐up of oncology patients is necessary for appropriate cardiac prevention and surveillance to enhance the health and quality of life of the ever‐increasing number of cancer survivors.

oncology